← Browse by Condition
Medical Condition

inflammatory arthritis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06037811 Phase 2
Recruiting

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Enrollment
30 pts
Location
Canada
Sponsor
Tom Appleton
View Trial →